Document is current
Any future updates will be listed below
-
Authors
,
Jansen, Klaus http://orcid.org/0000-0002-4878-9421
Steffen, Gyde
Potthoff, Anja
Schuppe, Ann-Kathrin
Beer, Daniel
Jessen, Heiko
Scholten, Stefan
Spornraft-Ragaller, Petra
Bremer, Viviane
Tiemann, Carsten
- License Information
-
More Information
Article History
Received: 17 September 2019
Accepted: 28 January 2020
First Online: 7 February 2020
Ethics approval and consent to participate
: The study protocol was approved by the Ethics Commission Charité - University Medicine Berlin, Germany (approval number EA1/256/16).We obtained a written informed consent of every included person on participation in the study and publication of the study results. We did not report individual patient data. Participation was voluntary and could be withdrawn at any time point without negative consequences for the participant.
: Not applicable.
: Heiko Jessen received funding from Gilead Sciences GmbH and U.S. Military HIV Research Program (MHRP); for Board membership from ViiV Healthcare GmbH and MSD GmbH; for speaker activities from ViiV Healthcare GmbH, Janssen-Cilag GmbH and Hormosan Pharma GmbH; and for travel/accommodation/meeting expenses from Gilead Sciences GmbH Janssen-Cilag GmbH, ViiV Healthcare GmbH and MSD GmbH. Klaus Jansen is an Editorial Board Member for BMC Infectious Diseases.
